-The Economic Times Arvind Panagariya, a professor of Indian economics at Columbia University, hits out at Nobel laureate and Harvard University professor Amartya Sen over his call to confront MPs with the "number of deaths" a delayed Food Security Bill can cause. The former chief economist at the Asian Development Bank counters Sen's argument that it is high social spending that has contributed to the economic growth of Asian economies such...
More »SEARCH RESULT
Building euphoria-Himanshu Upadhyaya
-Frontline But in Modi's Gujarat the difference between development and darkness is all too visible to those who care to see. NARENDRA MODI may have won three consecutive elections and ruled Gujarat for more than a decade after he was posted there almost as a night watchman, to borrow a cricketing expression. He may have mobilised a massive fan following that is shouting to catapult him into the Prime Minister's post,...
More »Panchayati raj: Failing the urbanization test- Elizabeth Roche, Liz Mathew and Shamsheer Yousaf
-Live Mint Lack of decentralization means municipalities lack power, resources to meet rising aspirations of ‘middle' India Othakadai, Madurai (Tamil Nadu)/Hubli (Karnataka): S. Paramasivam , president of the Othakadai panchayat, has big plans for his area. "Rainwater harvesting, removal of encroachments on roads, waste recycling, covered drainage, bigger primary health care centres and community parks," lists the 58-year-old, who has spent 30 years in the stainless steel business that dominates industry...
More »Social Justice
KEY TRENDS • According to National Sample Survey report no. 583: Persons with Disabilities in India, the percentage of persons with disability who received aid/help from Government was 21.8 percent, 1.8 percent received aid/help from organisation other than Government and another 76.4 percent did not receive aid/ help *8 • As per National Family Health Survey-4 (NFHS-4), the Under-five Mortality Rate (U5MR) was 57.2 per 1,000 live births (for the non-STs it was 38.5)...
More »SC’s Novartis judgement renews focus on accessible medicine
The recent Supreme Court judgment dismissing pharma giant Novartis’ claim for patent protections in India for its award-winning and prohibitively priced anti-leukemia drug Glivec has renewed the focus on accessibly-priced drugs – in particular the failure of the Indian public healthcare system and health policy to ensure affordable drugs for all. Studies show that as much as 70% of health spending in India comes from out-of-pocket payments, with 50-80% of...
More »